Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
BMC Gastroenterology 21(1) (2021)
Behnaz Amernia; Seyed Hamid Moosavy; Fatemeh Banookh; Ghazal Zoghi
Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis
Journal of Ethnopharmacology 264 (2020)
Yuan Zhou; Rong Wu; Feifei Cai; Wenjun Zhou; Yi-Yu Lu; Hui Zhang; Qilong Chen; Shi-Bing Su
High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
Scientific Reports 11(1) (2021)
Haruka Saito; Hayato Tanabe; Akihiro Kudo; Noritaka Machii; Moritake Higa; Satoshi Yamaguchi; Gulinu Maimaituxun; Kazumichi Abe; Atsushi Takahashi; Kenichi Tanaka; Koichi Asahi; Hiroaki Masuzaki; Hiromasa Ohira; Junichiro James Kazama; Michio Shimabukuro
De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke
Neuropsychiatric Disease and Treatment Volume 13 (2017)
Fan Gao; Chen Chen; Jun Lu; Jie Zheng; Xiancang Ma; Xingyun Yuan; Kang Huo; Jianfeng Han
A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
BMC Genomics 19(1) (2018)
Jie Liu; Yue Xiao; Xikun Wu; Lichun Jiang; Shurong Yang; Zhi‐Ming Ding; Zhuo Fang; Haiqing Hua; Mark Kirby; Jianyong Shou
The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients
Journal of Clinical Gastroenterology 52(3) (2017)
Amandeep Singh; Phuc Le; Maajid Mumtaz Peerzada; Rocío López; Naim Alkhouri
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers
Contemporary Clinical Trials 97 (2020)
Stephen A. Harrison; Salvatore Calanna; Kenneth J. Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun Jayant Sanyal; Anne‐Sophie Sejling; Philip Noel Newsome
Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study
Korean Journal of Radiology 18(6) (2017)
Shuangshuang Xie; Qing Li; Yue Cheng; Yu Zhang; Zhizheng Zhuo; Guiming Zhao; Wen Shen
Phase angle as a severity indicator for liver diseases
Nutrition 70 (2019)
Ana Paula Pagano; Juliana Maria Faccioli Sicchieri; Isabela Laurencio Schiavoni; D. Barbeiro; Camila Sanches Manca; Bruna Ramos da Silva; Amanda Escobar Bezerra; Lívia Cristina Mendonça Pinto; Roberta Chaves Araújo; Andreza Corrêa Teixeira; Paula Garcia Chiarello
Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
Marine Drugs 20(6) (2022)
Jiayao Feng; Yongjian Liu; Jiajia Chen; Yan Bai; Jincan He; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su
Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Diagnostics 11(5) (2021)
Sebastian Zenovia; C Stanciu; Catalin Victor Sfarti; Ana-Maria Sîngeap; Camelia Cojocariu; Irina Gîrleanu; Mihaela Dimache; Stefan Andrei Chiriac; Cristina Maria Muzica; Robert Năstasă; Laura Huiban; Tudor Cuciureanu; Anca Victorita Trifan
Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
World Journal of Hepatology 14(4) (2022)
Layal Al Nadaf; Mohammed Hussein Kamareddine; Emilie Fayad; Aniqa Hussain; Said G Farhat
Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
Cureus 13(8) (2021)
Bandana Kumari; Ramesh K. Kumar; Sadhana Sharma; Ayan Banerjee; Visesh Kumar; Pawan Kumar; Neha Chaudhary; Sushil Kumar; Khushboo Raj
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH
Liver International 44(12) (2024)
Laura Martínez‐Arenas; Carmen Vinaixa; Isabel Conde; Sara Lorente; Fernando Díaz‐Fontenla; Patrice Marqués; Judith Pérez‐Rojas; Eva María Montalvá; Ângela Carvalho‐Gomes; Marina Berenguer
Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
European journal of medical research 29(1) (2024)
Eman Helal; Fatma Elgebaly; Nasser Mousa; Sherif Elbaz; Mostafa Abdelsalam; Eman Abdelkader; Amr Ali Mohamed Abdelgawwad El‐Sehrawy; Niveen El‐Wakeel; Ola El-Emam; Manal Hashem; Alaa Elmetwalli; Shimaa Mansour
Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
Egyptian Liver Journal 10(1) (2020)
Ahmed M. F. Mansour; Essam Bayoumy; Ahmed Mohamed ElGhandour; Mohamed Darwish El-Talkawy; Sameh M. Badr; Ahmed Elmetwally Ahmed
Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway
Biomedicine & Pharmacotherapy 128 (2020)
Manman Chen; Jing-Wei Xing; Danqing Pan; Xiuhua Peng; Pengfei Gao
Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats
Chinese Medicine 16(1) (2021)
Yu Xiong; Jinyuan Hu; Chen Xuan; Jiayu Tian; Kaiyue Tan; Zhiwei Chen; Yan Luo; Xuqin Du; Junxiong Cheng; Lanyue Zhang; Wenfu Cao
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
Medicine 102(34) (2023)
Yuping Ding; Zuoyu Wang; Haiyan Niu; Quanjun Deng; Yanan Wang; Shihai Xia
Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection
Arab Journal of Gastroenterology 24(1) (2022)
Merve Sefa Sayar; Dilek Bulut; Ali Acar
Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
Biomedicines 12(11) (2024)
Joana D’Arc Matos França de Abreu; Rossana Santiago de Sousa Azulay; Vandílson Pinheiro Rodrigues; Sterffeson Lamare Lucena de Abreu; Maria da Glória Tavares; Flávia Coelho Mohana Pinheiro; Clariano Pires de Oliveira Neto; Caio Andrade; Alexandre Nogueira Facundo; Adriana Guimarães Sá; Patrícia Ribeiro Azevedo; Ana Gregória Ferreira Pereira de Almeida; Debora Camelo de Abreu Costa; Rogério Soares Castro; Marcelo Magalhães; Gilvan Cortês Nascimento; Manuel dos Santos Faria; Adalgisa de Souza Paiva Ferreira
The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients
Hepatology International 12(1) (2018)
Amandeep Singh; Phuc Le; Rocío López; Naim Alkhouri
Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study
Expert Review of Proteomics 17(7-8) (2020)
Paweł Małecki; Joanna Tracz; Magdalena Łuczak; Magdalena Figlerowicz; Katarzyna Mazur‐Melewska; Wojciech Służewski; Anna Mania
Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
Diagnostics 12(4) (2022)
Anca Victorita Trifan; Adrian Rotaru; Remus Stafie; Ermina Stratina; Sebastian Zenovia; Robert Năstasă; Laura Huiban; Tudor Cuciureanu; Cristina Maria Muzica; Stefan Andrei Chiriac; Irina Gîrleanu; Ana-Maria Sîngeap; Catalin Victor Sfarti; Camelia Cojocariu; C Stanciu
Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease
Diabetes Metabolic Syndrome and Obesity Volume 14 (2021)
Muhammad Shah Alam; Abul B. M. Kamrul-Hasan; Syeda Tanzina Kalam; SM Mizanur Rahman; Mohammad Izazul Hoque; Md Belalul Islam; Ajit Paul
Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes
Nutrition Metabolism and Cardiovascular Diseases 33(9) (2023)
Kálmán Benedikt Bódis; Maria Bombrich; Martin Schön; Birgit Knebel; Oana‐Patricia Zaharia; Gidon Josia Bönhof; Yanislava Karusheva; Klaus Straßburger; Yuliya Kupriyanova; Jörg Kotzka; Rainer Guthoff; Vera B. Schrauwen‐Hinderling; Hadi Al‐Hasani; Volker Burkart; Julia Szendroedi; Robert J. Wagner; Daniel F. Markgraf; Michael Roden
Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis
Digestive Diseases 41(5) (2022)
Michael Huan Le; Linda L Henry; Ramsey C Cheung; Mindie H. Nguyen
Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases
Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis 7.2(2) (2023)
Nasser Mousa; Ahmed El-Eraky; Mona Arafa; Hatem Elalfy; Raghda E. Farag; Ahmed Abdel‐Razik; Talaal Amer
Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine 13(21) (2024)
Iván Ferraz‐Amaro; Alejandro Hernández-Camba; Marta Carrillo Palau; Noemi Hernández Alvarez-Buylla; Antonia de Vera-González; Alejandra González Delgado; Elena Heras-Recuero; Miguel Ángel González-Gay
Diagnostic Accuracy of Red Cell Distribution Width to Platelet Ratio for the Prediction of Liver Fibrosis in Patients With Chronic Liver Disease From Eastern India
Cureus 17(4) (2025)
D Pavan Sai Kumar Rao; Shubhransu Patro; Vibha Sharma; Arushi Choudhary; Shubham Desale; Preetam Nath
Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups
Clinica Chimica Acta 586 (2026)
Nazmin Bithi; Sidharth Panda; Michael D. Dowlin; Sridevi Devaraj
The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease
International Heart Journal 60(5) (2019)
Tetsuro Yokokawa; Koichi Sugimoto; Akiomi Yoshihisa; Takuya Goto; Tomofumi Misaka; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study
International Journal of Molecular Sciences 22(18) (2021)
Ana Aguiar; Jaluza Luana Carvalho de Queiroz; Pedro Paulo de Andrade Santos; Christina da Silva Camillo; Alexandre Coelho Serquiz; Izael de Sousa Costa; Gerciane Silva de Oliveira; Ana Francisca Teixeira Gomes; Lídia Leonize Rodrigues Matias; Rafael O. Costa; Thaís Souza Passos; Ana Heloneida de Araújo Morais
Prevalence and clinical characteristics of NAFLD in chronic liver disease patients from King Abdulaziz University Hospital, Jeddah
Saudi Journal of Medicine and Medical Sciences 8(2) (2020)
Hind I. Fallatah; Ammar AlDabbagh; MohammeadT Hiejazi; Sulaiman A. Hanbazazah; AliO Hussein; Majed A. Al-Sahafi; Hisham Osman Akbar
Estimation of liver elasticity using the finite element method and four‐dimensional computed tomography images as a biomarker of liver fibrosis
Medical Physics 48(3) (2021)
Koya Fujimoto; Takehiro Shiinoki; Yuki Yuasa; Hidekazu Tanaka
Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study
Electronic Journal of General Medicine 16(3) (2019)
Marwan S.M. Al-Nimer; Vian Ahmed Wasta Esmail; O N Mohammad
Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
Cureus 14(1) (2022)
Bandana Kumari; Sadhana Sharma; Ramesh K. Kumar; Satish Pundlik Dipankar; Bijaya Nanda Naik; Ayan Banerjee; Sushil Kumar
Shear wave elastography reveals a high prevalence of liver fibrosis in overweight or obese Hispanic youth
Journal of Ultrasonography 20(82) (2020)
Sanjeet Sandhu; Carisse M. Orsi; Gary L. Francis; Zhu Wang; Roman A. Fernandez; Naim Alkhouri
Fibroscan Compared to Aspartate Aminotransferase to Platelet Ratio Index (APRI) and Aspartate Aminotransferase to Alanine Aminotransferase Ratio (AST to ALT) in the Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in a Terti
Pakistan Armed Forces Medical Journal 72(2) (2022)
Hasan Ikram; Syed Raza Jaffar; Asma Hayat; Mehnaz Khattak; Nauman Majeed; Afnan Naeem
Is Aspartate Aminotransferase to Platelet Ratio Index a Better Noninvasive Score for Predicting Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Patients?
Euroasian Journal of Hepato-Gastroenterology 14(1) (2024)
Priyansh Deven Bhayani; Sarojini Ashok Parameswaran; Kallipatti Ramasamy Palaniswamy; Piramanayagam Paramasivan; Natarajan Murugan
Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease
BMC Gastroenterology 25(1) (2025)
Hanaa Mostafa Badran; Maha Elsabaawy; Mai Magdy; Hazem Metwaly Omar; Olfat Mohamed Hendy; Eman Kamal Awaad; Maryam Alkhalifa; Mai Abozeid
Platelet Proteomics: A Glimpse Into Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis
Hepatology Research 56(4) (2025)
Iulia Minciună; Maria Iacobescu; Ioana Rusu; Oana Nicoară-Farcău; Petra Fischer; Maria-Andreea Soporan; Ioana-Ecaterina Pralea; Horia Ştefănescu; Cristina Adela Iuga; Bogdan Procopeț
Correlation between Serum Ferritin Levels and Liver Stiffness measured by Fibroscan in patients with Chronic Hepatitis C
Pakistan Journal of Medical Sciences 36(3) (2020)
Saba Latif; Quratulain Kalam; Bader Faiyaz Zuberi
Non-invasive Methods in Diagnosis of Nonalcoholic Fatty Liver Disease
The Egyptian Journal of Hospital Medicine 83(1) (2021)
Khaled Hemida; Hany Haroun; Inas Elkhedr Mohamed; Mostafa Mahmoud
CORRELATION OF FIB-4 AND APRI SCORE WITH FIBRO SCAN SCORE TO PREDICT FIBROSIS IN OBESE TYPE-2 DIABETIC PATIENTS.
Student s Journal of Health Research Africa 4(12) (2023)
Amit Kumar Das; Anuj Sharma; Mohammad Zahid Labrez
Prevalence of non-alcoholic steatohepatitis in a general population of North Karnataka
THE SCIENTIFIC TEMPER 14(04) (2023)
Geeta S Desai; Santosh Hajare; Sangeeta N Kharde
Liver stiffness in 10 patients with non-alcoholic fatty liver disease before and after luseogliflozin administration
Kanzo 59(10) (2018)
Toshihiro Sato
Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans
Journal of Viral Hepatitis 27(10) (2020)
Martin Tibuakuu; Caroline J Jjingo; Gregory Dale Kirk; David L. Thomas; Ronald Henry Gray; Victor Ssempijja; Fred Kakaire Nalugoda; David Serwadda; Ponsiano Ocama; Christopher Opio; David Erwin Kleiner; Thomas C. Quinn; Steven James Reynolds
Recomendaciones en el tratamiento actual de la infección crónica por el virus de la hepatitis B
Hepatología (2020)
Víctor Deioxes Escandón-Felizzola
ASSESSMENT OF LIVER STIFFNESS IN NONALCOHOLIC FATTY LIVER DISEASE
Zagazig University Medical Journal 24(8) (2018)
Role of Controlled Attenuation Parameter in Metabolic Associated Fatty Liver Disease Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases 0(0) (2022)
Yehia El-Khashab; Tarik I. Zaher; Noha Shaheen; Sameh Abdel Monem
Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease
Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis 6.3(3) (2022)
Ahmed Mohammed Mosaad; Hatem Elalfy; Talaal Amer; Mona Arafa
The Correlation Between Fibroscan and APRI Score in Non Alcoholic Fatty Liver Disease Patients for Assessing Liver Fibrosis Degree : A Literature Review
International Journal of Research Publications 115(1) (2022)
Luthfan Hakim Sanusi; Husin Thamrin
Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms
Laboratory Medicine Online 13(3) (2023)
Min-Kyeong Kim; Heon‐Ju Kwon; Kangsu Shin; Hyosoon Park; Hee‐Yeon Woo; Chang‐Hun Park; Min‐Jung Kwon
Fibroscan and Low-Density Lipoprotein Versus Non-invasive Markers (APRI test and FIB-4) As Determinants of Severe Liver Fibrosis in Egyptian Diabetic Patients With Non-Alcoholic Fatty Liver Disease
Al-Azhar International Medical Journal /Al-Azhar International Medical Journal 4(6) (2023)
Esmail Anwar Esmail; Mohamed Elnadry; Mohamed Mousa Hegazy; Mohamed Mahmoud Abdelhalim; Mohamed Hassani Barbari
Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients
Diabetes Metabolic Syndrome and Obesity Volume 17 (2024)
Yuping Ding; Guiqiang Wang; Quanjun Deng; Mei Yang; Jinghua Li; Zuoyu Wang; Haiyan Niu; Shihai Xia
The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy
Clinical and Experimental Nephrology 28(11) (2024)
Hailang Wei; Bingqing Liao; Qi Zhou; Xuhua Zhou; Yue Zhong; Yanbin Hao; Fuhua Xie; Runxiu Wang
Comparison of Fibrosis-4 with FibroScan for Liver Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease Patients: A Cross-sectional Study
Journal of the Dow University of Health Sciences 18(2) (2024)
Fahad Kakar; Arif Rasheed Siddiqui; Saad Khalid Niaz; Syed Afzal Ul Haq Haqqi; Zea Ul Islam Farrukh; Muhammad Danish Ashraf Wallam; Muhammad Umar Farooq; Sayed Rohail Ahmed Rizvi
Significance of Correlation of Shear Wave Elastography With Fibrosis-4 in a Cohort of Patients With Diabetes and Nonalcoholic Fatty Liver Disease
Cureus 16(8) (2024)
Rohan Kelkar; Uday Phadke; Raveena Kelkar; Shalmi Khanapurkar; Nishad Barve
A clinical case of non-alcoholic fatty liver disease with polycystic ovary syndrome
Terapevt (General Physician)(7) (2025)
Дударева Лариса Андреевна; Tkachev Av; А. M. Aslanov; Galina N. Tarasova; В. А. Косенко; Мазовка Карина Евгеньевна; E. N. Veselova; Мкртчян Лиана Сирекановна; L.V. Sudyina; Yu. Yu. Chebotareva
Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population
Exploration of Endocrine and Metabolic Diseases 2 (2025)
Jianmin Tang; Aheyeerke Halengbieke; Chao Tong; Xuetong Ni; Tengrui Cao; Yumei Han; Shuo Chen; Linrun Kong; Xinghua Yang
Clinical utility of non-invasive markers in the assessment of liver fibrosis among type 2 diabetes mellitus patients
Turkish Journal of Biochemistry 51(4) (2026)
Thilak Priyantha Weerarathna; Keddagoda Gamage Piyumi Wasana; Iroshani Kodikara; Suneth Ruwan Weerarathna
Comparative evaluation of noncontrast computed tomography (CT) histogram analysis, FibroScan, and serum markers for liver fibrosis assessment in chronic hepatitis B patients
Clinical Radiology 100 (2026)
Murat İspiroğlu; Ceyda Ören; Murat Baykara; Gülay Güngör
Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study
BMC Gastroenterology 26(1) (2026)
Hossein Bagheri; Niloofar Seighali; Mohammad Sadra Gholami Chahkand; Mahmood Bakhtiyari; Fateme Seighali; Fatemeh Jodeiri; Mohsen Rajabnia
Creatinine-to-body weight ratio as a marker of metabolic dysfunction and obesity-related steatosis in Egyptian patients
Egyptian Liver Journal 16(1) (2026)
Shimaa Ebrahim; Ebtesam Shady; Shimaa Moustafa Mansour